MEDTECH — Acquisition related costs
Business Segments · Acquisition related costsYear-over-year, this metric declined by 66.7%, from $300.00M to $100.00M.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2023
Last reportedQ3 2025
Rolls up toAcquisition and integration costs
How to read this metric
High costs indicate aggressive inorganic growth, while low costs suggest a focus on organic integration and stability.
Detailed definition
These are the costs directly associated with the acquisition of other businesses or technologies within the medical tech...
Peer comparison
Standard line item for companies pursuing growth through mergers and acquisitions.
Metric ID:
jnj_segment_medtech_acquisition_related_costsHistorical Data
11 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $50.00M | $50.00M | $50.00M | $50.00M | $100.00M | $600.00M | $300.00M | $0.00 | $100.00M | $0.00 | $100.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +100.0% | +500.0% | -50.0% | -100.0% | — | -100.0% | — |
| YoY Change | — | — | — | — | +100.0% | >999% | +500.0% | -100.0% | +0.0% | -100.0% | -66.7% |
Range$0.00 – $600.00M
CAGR+32.0%
Avg YoY Growth+204.8%
Median YoY Growth+0.0%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Johnson & Johnson's medtech — acquisition related costs?
- Johnson & Johnson (JNJ) reported medtech — acquisition related costs of $100.00M in Q3 2025.
- How has Johnson & Johnson's medtech — acquisition related costs changed year-over-year?
- Johnson & Johnson's medtech — acquisition related costs decreased by 66.7% year-over-year, from $300.00M to $100.00M.
- What does medtech — acquisition related costs mean?
- One-time expenses incurred while buying or integrating other companies into the medical technology segment.